Valuation: ChronoScale Holdings Corporation

Market Cap 2.64B 2.28B 2.15B 1.95B 3.67B 253B 3.72B 25.17B 9.86B 127B 9.91B 9.7B 421B P/E 2024 *
-
P/E 2025 -
Enterprise Value 2.86B 2.47B 2.32B 2.11B 3.97B 274B 4.03B 27.24B 10.68B 137B 10.73B 10.5B 456B EV / Sales 2024 *
-
EV / Sales 2025 2.71x
Free-Float
1.46%
Yield 2024 *
-
Yield 2025 -
1 day+1.50%
1 week+8.61%
Current month-4.99%
1 month-20.81%
3 months+32.22%
6 months+61.62%
Current year+142.25%
1 week 20.17
Extreme 20.17
24.03
1 month 17.11
Extreme 17.11
29.5
Current year 6.93
Extreme 6.93
30
1 year 3.05
Extreme 3.05
30
3 years 2.73
Extreme 2.73
46.93
5 years 2.73
Extreme 2.73
77.6
10 years 2.73
Extreme 2.73
1,435.5
Date Insider Type Main position Quantity % Market Cap.
7/22/26 Free

Chief Technology Officer

1,400,000 0.9784%
7/19/26 Other

Chief Technology Officer

2,587 0.0018%
7/13/26 Free

Chief Executive Officer

2,800,000 1.9568%
Change 5-day change 1-year change 3-year change Capi.($)
+9.89%+8.61%+545.99%+49.33% 3.38B
+4.78%+2.27%+23.76%+15.87% 218B
+6.18%+2.26%-0.83%-15.88% 140B
+3.41%+0.52%-15.82%+40.71% 138B
+3.78%+0.66%-50.11%+2.66% 73.14B
+2.06%-0.48%+17.33%+21.32% 52.44B
+1.32%+2.13%-16.40%-12.36% 50.85B
+4.61%+4.21%+28.62%+29.97% 41.92B
+3.83%-0.07%+39.68%+55.65% 39.42B
+3.76%+3.68%+1.31%+8.66% 32.81B
Average +3.52%-0.98%+57.35%+19.59% 79.03B
Weighted average by Cap. +4.17%-2.35%+4.98%+14.47%

Financials

*1 *
Net sales - -
Net income - -
Net Debt - -
Logo ChronoScale Holdings Corporation
ChronoScale Corporation, formerly Ekso Bionics Holdings, Inc., designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The Company operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. It assists people to perform challenging repetitive tasks for extended periods.
Employees
-
Date Price Change Volume
26-08-13 US$20.93 +1.50% 99,842
26-08-18 US$23.53 +6.04% 162,017
26-08-17 US$22.19 +6.02% 107,362
26-08-14 US$20.93 +1.50% 99,842
26-08-13 US$20.62 -0.82% 120,635
  1. Stock Market
  2. Stocks
  3. CHRN Stock